BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2481407)

  • 1. Potent cholecystokinin antagonist L 364718 stimulates food intake in rats.
    Reidelberger RD; O'Rourke MF
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1512-8. PubMed ID: 2481407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of CCK antagonist L 364718 on meal-induced pancreatic secretion in rats.
    O'Rourke MF; Reidelberger RD; Solomon TE
    Am J Physiol; 1990 Feb; 258(2 Pt 1):G179-84. PubMed ID: 1689547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin receptors and vagal nerves in control of food intake in rats.
    Garlicki J; Konturek PK; Majka J; Kwiecien N; Konturek SJ
    Am J Physiol; 1990 Jan; 258(1 Pt 1):E40-5. PubMed ID: 2301570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
    Louie DS; Liang JP; Owyang C
    Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin suppresses food intake by a nonendocrine mechanism in rats.
    Reidelberger RD; Varga G; Liehr RM; Castellanos DA; Rosenquist GL; Wong HC; Walsh JH
    Am J Physiol; 1994 Oct; 267(4 Pt 2):R901-8. PubMed ID: 7524371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of BIM-18216, a novel cholecystokinin receptor antagonist, on food intake reduction induced by cholecystokinin.
    Laferrere B; Nguyen M; Bonhomme G; Legall A; Basdevant A; Guy-Grand B
    Behav Neurosci; 1991 Oct; 105(5):707-11. PubMed ID: 1815620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a new diphenylpyrazolidinone cholecystokinin antagonist in vitro isolated rat pancreatic acini.
    Akiyama T; Tachibana I; Otsuki M
    Int J Pancreatol; 1993 Oct; 14(2):167-73. PubMed ID: 7506744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin-A receptor mediation of food intake in cats.
    Bado A; Durieux C; Moizo L; Roques BP; Lewin MJ
    Am J Physiol; 1991 Apr; 260(4 Pt 2):R693-7. PubMed ID: 2012242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-related involvement of CCK in bombesin-induced pancreatic growth.
    Liehr RM; Reidelberger RD; Rosewicz S; Bussjaeger LJ; Solomon TE
    Regul Pept; 1992 Apr; 38(3):207-19. PubMed ID: 1375383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCK satiety is differentially mediated by high- and low-affinity CCK receptors in mice and rats.
    Weatherford SC; Laughton WB; Salabarria J; Danho W; Tilley JW; Netterville LA; Schwartz GJ; Moran TH
    Am J Physiol; 1993 Feb; 264(2 Pt 2):R244-9. PubMed ID: 8447480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exocrine effects of the CCK antagonist L-364,718 in canine pancreatic autografts.
    Garvin PJ; Niehoff ML; Burton FR; Dysarz FA; Meadow R; Solomon H
    J Surg Res; 1996 Feb; 61(1):256-9. PubMed ID: 8769975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a physiological role for CCK in the regulation of food intake in mice.
    Silver AJ; Flood JF; Song AM; Morley JE
    Am J Physiol; 1989 Mar; 256(3 Pt 2):R646-52. PubMed ID: 2923253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.
    Lotti VJ; Pendleton RG; Gould RJ; Hanson HM; Chang RS; Clineschmidt BV
    J Pharmacol Exp Ther; 1987 Apr; 241(1):103-9. PubMed ID: 2437282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asperlicin: a unique nonpeptide cholecystokinin antagonist.
    Zucker KA; Adrian TE; Zdon MJ; Ballantyne GH; Modlin IM
    Surgery; 1987 Aug; 102(2):163-70. PubMed ID: 2441481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals.
    Zucker KA; Adrian TE; Bilchik AJ; Modlin IM
    Am J Physiol; 1989 Oct; 257(4 Pt 1):G511-6. PubMed ID: 2478030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence against cholecystokinin mediation of basal and bombesin-stimulated pancreatic secretion in the rat.
    Wisner JR; Ozawa S; Renner IG
    Gastroenterology; 1988 Jul; 95(1):151-5. PubMed ID: 3371609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
    Nylander AG; Chen D; Ihse I; Rehfeld JF; HÃ¥kanson R
    Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Devazepide antagonizes the inhibitory effect of cholecystokinin on intake in sham-feeding rats.
    Melville LD; Smith GP; Gibbs J
    Pharmacol Biochem Behav; 1992 Nov; 43(3):975-7. PubMed ID: 1448494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of atropine on pancreatic response to bethanechol, cholecystokinin, and food intake in rats.
    O'Rourke MF; Reidelberger RD; Solomon TE
    Am J Physiol; 1991 Nov; 261(5 Pt 1):G735-41. PubMed ID: 1683164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin octapeptide decreases food intake in white-crowned sparrows.
    Richardson RD; Boswell T; Weatherford SC; Wingfield JC; Woods SC
    Am J Physiol; 1993 May; 264(5 Pt 2):R852-6. PubMed ID: 8498593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.